12.15.22
Approximately 12 million people in the United States are dually eligible for Medicare and Medicaid.
12.12.22
In 2021, drug-related overdose deaths topped 107,000.
12.09.22
Section 1115 demonstrations, also called “waivers,” allow states to test new ways to operate their Medicaid programs, typically for matters related to eligibility, benefits and care delivery.
12.08.22
Massachusetts’ historical achievements in innovative health care policy have positioned the state as a national leader in transforming health care coverage, access, affordability and quality.
12.06.22
Section 1115 Medicaid demonstrations are a powerful tool for states to pursue a range of innovative programs aimed at improving the health and well-being of Medicaid enrollees.
12.05.22
In 2020, health care spending in the United States increased by nearly 10 percent to reach $4.1 trillion, or 20 percent of the U.S. economy.
The 340B Drug Pricing Program, which was enacted in 1992 by Section 340B of the federal Public Health Services Act, requires pharmaceutical manufacturers that participate in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health care providers ...
11.18.22
State policymakers are increasingly focused on strategies to ensure access to and affordability of health care coverage for immigrant populations, especially in light of the significant burden that the COVID-19 pandemic has placed on people who are uninsured.
11.17.22
Research shows that personal behaviors, physical environments and socioeconomic factors—commonly referred to as the social drivers of health—are responsible for 80 percent of health outcomes.
11.14.22
We have entered an era of digitally enabled care—fully integrated in-person and virtual care models that hybridize care delivery based on clinical appropriateness and other factors, such as convenience and cost.